Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension

Oncotarget

Volumn 7, Issue 34, 2016, Pages 54263-54273

  Wang, Guo Kun ^a   Li, Song Hua ^a   Zhao, Zhi Min ^a   Liu, Su Xuan ^a   Zhang, Guan Xin ^a   Yang, Fan ^a   Wang, Yang ^a   Wu, Feng ^b   Zhao, Xian Xian ^a   Xu, Zhi Yun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Cardiology   (China)

Author keywords

Heat shock protein 90; Pathology Section; Pulmonary arterial hypertension; Pulmonary arteriole remodeling; Pulmonary artery smooth muscle cells

Indexed keywords

HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TANESPIMYCIN; BENZOQUINONE DERIVATIVE; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 4; MACROCYCLIC LACTAM;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INHIBITION; PULMONARY ARTERIOLE REMODELING; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; VASCULAR REMODELING; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ADULT; ARTERIOLES; BENZOQUINONES; CYCLIN-DEPENDENT KINASE 4; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; HYPERTENSION, PULMONARY; LACTAMS, MACROCYCLIC; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; SIGNAL TRANSDUCTION; VASCULAR REMODELING;

EID: 84983504232     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10855     Document Type: Article

References (19)

1. Sakao S and Tatsumi K. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities. International journal of cardiology. 2011; 147:4-12.
2. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM and Souza R. Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology. 2013; 62:D34-41.
3. Crosswhite P and Sun Z. Molecular mechanisms of pulmonary arterial remodeling. Mol Med. 2014; 20:191-201.
4. Ma L and Chung WK. The genetic basis of pulmonary arterial hypertension. Human genetics. 2014; 133:471-479.
5. Mayer MP and Le Breton L. Hsp90: Breaking the Symmetry. Molecular cell. 2015; 58:8-20.
6. Echeverria PC and Picard D. Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility. Biochimica et biophysica acta. 2010; 1803:641-649.
7. Calderwood SK, Khaleque MA, Sawyer DB and Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends in biochemical sciences. 2006; 31:164-172.
8. Taipale M, Jarosz DF and Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nature reviews Molecular cell biology. 2010; 11:515-528.
9. Madrigal-Matute J, Lopez-Franco O, Blanco-Colio LM, Munoz-Garcia B, Ramos-Mozo P, Ortega L, Egido J and Martin-Ventura JL. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovascular research. 2010; 86:330-337.
10. Kim J, Jang SW, Park E, Oh M, Park S and Ko J. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis. Journal of molecular and cellular cardiology. 2014; 72:157-167.
11. Wang X, Song X, Zhuo W, Fu Y, Shi H, Liang Y, Tong M, Chang G and Luo Y. The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106:21288-21293.
12. Huang J, Wolk JH, Gewitz MH and Mathew R. Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension. Experimental lung research. 2010; 36:57-66.
13. Ou ZJ, Wei W, Huang DD, Luo W, Luo D, Wang ZP, Zhang X and Ou JS. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats. American journal of physiology Endocrinology and metabolism. 2010; 298:E1131-1139.
14. Gallo LI, Lagadari M, Piwien-Pilipuk G and Galigniana MD. The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress. The Journal of biological chemistry. 2011; 286:30152-30160.
15. Sanderson S, Valenti M, Gowan S, Patterson L, Ahmad Z, Workman P and Eccles SA. Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis. Molecular cancer therapeutics. 2006; 5:522-532.
16. Tse AN, Klimstra DS, Gonen M, Shah M, Sheikh T, Sikorski R, Carvajal R, Mui J, Tipian C, O'Reilly E, Chung K, Maki R, Lefkowitz R, Brown K, Manova-Todorova K, Wu N, et al. A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors. Clinical cancer research. 2008; 14:6704-6711.
17. Goetz MP, Toft D, Reid J, Ames M, Stensgard B, Safgren S, Adjei AA, Sloan J, Atherton P, Vasile V, Salazaar S, Adjei A, Croghan G and Erlichman C. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. Journal of clinical oncology. 2005; 23:1078-1087.
18. Shi Y, Liu X, Lou J, Han X, Zhang L, Wang Q, Li B, Dong M and Zhang Y. Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses. Clinical cancer research. 2014; 20:6016-6022.
19. Joppa P, Petrasova D, Stancak B and Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest. 2006; 130:326-333.